MY178249A - Solid dialysis a agent containing alkali metal diacetate, and two-part type low-acetate dialysis agent using same - Google Patents
Solid dialysis a agent containing alkali metal diacetate, and two-part type low-acetate dialysis agent using sameInfo
- Publication number
- MY178249A MY178249A MYPI2016701186A MYPI2016701186A MY178249A MY 178249 A MY178249 A MY 178249A MY PI2016701186 A MYPI2016701186 A MY PI2016701186A MY PI2016701186 A MYPI2016701186 A MY PI2016701186A MY 178249 A MY178249 A MY 178249A
- Authority
- MY
- Malaysia
- Prior art keywords
- dialysis
- agent
- acetic acid
- solid
- acetate
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 title abstract 7
- 238000000502 dialysis Methods 0.000 title abstract 7
- 239000007787 solid Substances 0.000 title abstract 5
- 229910052783 alkali metal Inorganic materials 0.000 title abstract 2
- 150000001340 alkali metals Chemical class 0.000 title abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 12
- 239000000385 dialysis solution Substances 0.000 abstract 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 159000000021 acetate salts Chemical class 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- 150000001242 acetic acid derivatives Chemical class 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
To provide a solid dialysis A agent which is to be used in preparing a bicarbonate dialysis fluid, which enables the setting of a low total acetate ion content in a dialysis fluid, and which exhibits excellent storage stability of glucose or the like and a reduced acetic acid odor. [Solution] A solid dialysis A agent which is to be used in preparing a bicarbonate dialysis fluid, wherein: the solid dialysis A agent contains glucose, acetic acid and an acetate salt; at least a part of a mixture of the acetic acid with the acetate salt is an alkali metal diacetate; and the acetic acid/acetate salt molar ratio is adjusted to 1/0.5 to 1/2. This solid dialysis A agent makes it possible to prepare a bicarbonate dialysis fluid which has a total acetate ion concentration of 2 to less than 6 mEq/L. Further, the dialysis A agent exhibits excellent stability of ingredients and a reduced acetic acid odor.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013207382A JP5517322B1 (en) | 2013-10-02 | 2013-10-02 | Three-part dialysis agent containing acetic acid and acetate |
| PCT/JP2014/076372 WO2015050188A1 (en) | 2013-10-02 | 2014-10-02 | Solid dialysis a agent containing alkali metal diacetate, and two-part type low-acetate dialysis agent using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY178249A true MY178249A (en) | 2020-10-07 |
Family
ID=51031258
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2016701187A MY176214A (en) | 2013-10-02 | 2014-10-02 | Three-pack type dialysis agent containing acetic acid and acetic acid salt |
| MYPI2016701186A MY178249A (en) | 2013-10-02 | 2014-10-02 | Solid dialysis a agent containing alkali metal diacetate, and two-part type low-acetate dialysis agent using same |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2016701187A MY176214A (en) | 2013-10-02 | 2014-10-02 | Three-pack type dialysis agent containing acetic acid and acetic acid salt |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP5517322B1 (en) |
| KR (1) | KR102363179B1 (en) |
| MY (2) | MY176214A (en) |
| PH (1) | PH12016500571B1 (en) |
| SG (1) | SG11201602533QA (en) |
| WO (1) | WO2015050189A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5376480B1 (en) | 2012-10-10 | 2013-12-25 | 富田製薬株式会社 | A dialysis agent containing acetic acid and acetate, and two-agent dialysis agent using the same |
| JP5517321B1 (en) | 2013-10-02 | 2014-06-11 | 富田製薬株式会社 | Solid dialysis agent A containing alkali metal diacetate, and two-agent type low-acetate dialysis agent using the same |
| JPWO2015072494A1 (en) | 2013-11-12 | 2017-03-16 | 扶桑薬品工業株式会社 | Novel sodium diacetate crystal and solid dialysis preparation containing the crystal |
| JP6562336B2 (en) * | 2014-12-11 | 2019-08-21 | 富田製薬株式会社 | Method for producing granulated material used for dialysis agent A |
| JP6681408B2 (en) * | 2015-03-31 | 2020-04-15 | ガンブロ・ルンディア・エービーＧａｍｂｒｏ Ｌｕｎｄｉａ Ａｂ | Package for acidic dialysate concentrate containing citrate and glucose |
| JP6467285B2 (en) * | 2015-05-13 | 2019-02-13 | 富田製薬株式会社 | Granules for agent A for dialysis and method for producing the same |
| JP6312957B1 (en) * | 2016-10-28 | 2018-04-18 | 富田製薬株式会社 | Agent A for hemodialysis |
| CN110522763A (en) * | 2019-10-08 | 2019-12-03 | 四川太平洋药业有限责任公司 | A kind of Multiple electrolytes injection and preparation process |
| CN117838624A (en) * | 2023-11-29 | 2024-04-09 | 南京红太阳医药研究院有限公司 | A kind of Procaterol hydrochloride oral solution and preparation method thereof |
| CN119564851B (en) * | 2024-12-05 | 2025-08-22 | 广州骐骥生物科技有限公司 | A glacial acetic acid dialysis concentrate and its preparation method |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0599464A (en) | 1991-10-08 | 1993-04-20 | Nec Corp | Air shower device |
| EP0613688B2 (en) | 1993-02-19 | 2004-08-18 | Wilfried Dr.-Ing. Schäl | Process for preparing a bicarbonate containing dialysis liquid for the hemodialysis |
| JP2809971B2 (en) | 1993-07-06 | 1998-10-15 | 扶桑薬品工業株式会社 | Hemodialysis preparation |
| JP3433979B2 (en) * | 1993-08-24 | 2003-08-04 | 日機装株式会社 | Dialysis agent and method for producing the same |
| JP3619921B2 (en) | 1996-09-13 | 2005-02-16 | 富田製薬株式会社 | Bicarbonate solid dialysis agent |
| EP1008341B1 (en) * | 1997-08-22 | 2004-06-30 | Shimizu Pharmaceutical Co., Ltd. | Glucose-containing preparation |
| JP3586767B2 (en) * | 2000-04-06 | 2004-11-10 | 富田製薬株式会社 | Preparation method and adjustment device for dialysate |
| JP5204359B2 (en) | 2001-09-28 | 2013-06-05 | 味の素株式会社 | Dialysis agent and method for producing the same |
| CN1189180C (en) * | 2003-04-30 | 2005-02-16 | 广州康盛生物科技有限公司 | Bicarbonate dry powder composition for hemodialysis |
| US20070231395A1 (en) | 2004-03-30 | 2007-10-04 | Toshiya Kai | Solid Pharmaceutical Preparation for Dialysis |
| WO2010112570A1 (en) | 2009-03-31 | 2010-10-07 | Gambro Lundia Ab | Dialysis solution |
| JP5099464B1 (en) * | 2011-12-29 | 2012-12-19 | 富田製薬株式会社 | Bicarbonate ion concentration-variable dialysate preparation device and preparation method, bicarbonate ion concentration-variable dialysate, and bicarbonate ion concentration-variable dialyzing system |
-
2013
- 2013-10-02 JP JP2013207382A patent/JP5517322B1/en active Active
-
2014
- 2014-10-02 SG SG11201602533QA patent/SG11201602533QA/en unknown
- 2014-10-02 KR KR1020167011118A patent/KR102363179B1/en active Active
- 2014-10-02 MY MYPI2016701187A patent/MY176214A/en unknown
- 2014-10-02 MY MYPI2016701186A patent/MY178249A/en unknown
- 2014-10-02 WO PCT/JP2014/076373 patent/WO2015050189A1/en not_active Ceased
-
2016
- 2016-03-29 PH PH12016500571A patent/PH12016500571B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12016500571A1 (en) | 2016-06-20 |
| MY176214A (en) | 2020-07-24 |
| JP5517322B1 (en) | 2014-06-11 |
| PH12016500571B1 (en) | 2016-06-20 |
| SG11201602533QA (en) | 2016-05-30 |
| WO2015050189A1 (en) | 2015-04-09 |
| JP2015070908A (en) | 2015-04-16 |
| KR102363179B1 (en) | 2022-02-14 |
| KR20160064181A (en) | 2016-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016500572A1 (en) | Solid dialysis a agent containing alkali metal diacetate, and two-part type low-acetate dialysis agent using same | |
| PH12015500702A1 (en) | Dialysis a agent comprising acetic acid and acetate, and two-part dialysis agent using same | |
| PH12016500571A1 (en) | Three-pack type dialysis agent containing acetic acid and acetic acid salt | |
| WO2011161056A3 (en) | Dialysis precursor composition | |
| WO2014066468A8 (en) | Stable, low viscosity antibody formulation | |
| MX2012003296A (en) | Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin. | |
| JO2944B1 (en) | Long - acting formulations of insulin | |
| ZA202210899B (en) | Solutons for increasing the stability and shelf life of an organ and tissue preservation solution | |
| PH12015502542A1 (en) | Stabilized pemetrexed formulation | |
| ZA201504284B (en) | Solution for preserving vascular conduits | |
| EP4613284A3 (en) | Treatment of diabetes mellitus by long-acting formulations of insulins | |
| IN2012DN05192A (en) | ||
| HRP20210234T1 (en) | Formulations for stabilizing moisture in muscle foods | |
| MY164794A (en) | Liquid preparation for the reduction of free oxygen and the preservation of water | |
| RU2017102325A (en) | ROCURONIA DRUG WITH IMPROVED STABILITY | |
| MY186310A (en) | Infusion preparation | |
| MX2015001508A (en) | The use of antithrombin in extracorporeal membrane oxygenation. | |
| GR1008734B (en) | A water olive extract with metabolic and cardioprotective properties. | |
| CA2903759C (en) | Concentrated aqueous azalide formulations | |
| CN105434460A (en) | Medical pure sodium bicarbonate dialysis dry powder | |
| WO2015044081A3 (en) | Preservative free, acid stable, tea and honey concentrate | |
| TH162328A (en) | Dialysis A solid-type agent containing alkali metal diacetate, and low-acetate two-component dialysis agent using the same. | |
| EP2465357A3 (en) | Stabilized ß cryptoxanthin-containing water and the use thereof | |
| Olga | Influence of the sodium salt of carboxymethylcellulose on the surface properties of solutions of sodium dodecyl sulphate | |
| UA101070C2 (en) | antibacterial agent for infusions |